NAV
₹541.5241
as of 16 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +11.21%
- 3Y
- +24.85%
- 5Y
- +16.86%
- Since Inception
- +17.76%
SIP returns (XIRR)
- 1Y
- +19.35%
- 3Y
- +18.35%
- 5Y
- +20.53%
- Since Inception
- +17.24%
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology64.83%
- Healthcare Services24.43%
- Chemicals & Petrochemicals5.58%
- Healthcare Equipment & Supplies2.24%
- Retailing0.30%
Each sector links to the mutual funds most exposed to it.
Thinking about SBI Healthcare Opportunities Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH
- 1Sun Pharmaceutical Industries Ltd.11.71%
- 2Divi'S Laboratories Ltd.6.77%
- 3Acutaas Chemicals Ltd.5.40%
- 4Apollo Hospitals Enterprise Ltd.5.30%
- 5Max Healthcare Institute Ltd.5.17%
- 6Aster Dm Healthcare Ltd.3.89%
- 7Lupin Ltd.3.84%
- 8Torrent Pharmaceuticals Ltd.3.48%
- 9Anthem Biosciences Ltd.3.45%
- 10Aether Industries Ltd.3.35%
Investment Objective
SBI Healthcare Opportunities Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations